Design of 5' untranslated sequences in retroviral vectors developed for medical use

Journal of Virology

Volumn 73, Issue 5, 1999, Pages 4083-4089

  Hildinger, Markus ^a   Abel, Kristin L ^a   Ostertag, Wolfram ^a   Baum, Christopher ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GAG PROTEIN; GREEN FLUORESCENT PROTEIN; RNA; VIRUS PROTEIN; VIRUS VECTOR;

ARTICLE; GENE MUTATION; GENE TRANSFER; GENETIC RECOMBINATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; TRANSGENE; VIRUS GENE;

EID: 0032899919     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.5.4083-4089.1999     Document Type: Article

References (28)

1. Anderson, W. F., G. J. McGarrity, and R. C. Moen. 1993. Report to the NIH recombinant DNA advisory committee on murine replication competent retrovirus (RCR) assay. Hum. Gene Ther. 4:311-321.
2. Armentano, D., S.-F. Yu, P. W. Kantoff, T. von Rüden, W. F. Anderson, and E. Gilboa. 1987. Effect of internal viral sequences on the utility of retroviral vectors. J. Virol. 61:1647-1650.
3. Baum, C., S. Hegewisch-Becker, H.-G. Eckert, C. Stocking, and W. Ostertag. 1995. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J. Virol. 69:7541-7547.
4. Baum, C., C. Stocking, T. Wagener, H.-G. Eckert, and W. Ostertag. 1997. Gene transfer and transgene expression in hematopoietic cells, p. 233-266. In M. Strauss and J. A. Barranger (ed.), Concepts in gene therapy. De Gruyter, Berlin, Germany.
5. Baum, C., K. Itoh, J. Meyer, C. Laker, Y. Ito, and W. Ostertag. 1997. The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBF. J. Virol. 71:6323-6331.
6. Bender, M. A., T. D. Palmer, R. E. Gelinas, and A. D. Miller. 1987. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J. Virol. 61:1639-1646.
7. Berkowitz, R., J. Fisher, and S. P. Goff. 1996 RNA packaging. Curr. Top. Microbiol. Immunol. 214:177-218.
8. Berlioz, C., and J.-L. Darlix. 1995. An internal ribosomal entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors. J. Virol. 69:2214-2222.
9. Boeck, R., and D. Kolakofsky. 1994. Positions +5 and +6 can be major determinants of the efficiency of non-AUG initiation codons for protein synthesis. EMBO J. 13:3608-3617.
10. Bonini, C., G. Ferrari, S. Verzeletti, P. Servida, E. Zappone, L. Ruggieri, M. Ponzoni, S. Rossini, F. Mavilio, C. Traversari, and C. Bordignon. 1997. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276:1719-1724.
11. Coffin, J. M. 1996. Retroviridae: the viruses and their replication, p. 763-844. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.) Fundamental virology. Lippincott-Raven Publishers, Philadelphia, Pa.
12. Colicelli, J., and S. P. Goff. 1986. Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. J. Virol. 57:37-45.
13. Eckert, H.-G., M. Stockschläder, U. Just, S. Hegewisch-Becker, M. Grez, A. Zander, W. Ostertag, and C. Baum. 1996. High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors. Blood 88:3407-3415.
14. Hildinger, M., B. Fehse, S. Hegewisch-Becker, J. John, J. A. Rafferty, W. Ostertag, and C. Baum. 1998. Dominant selection of hematopoietic progenitor cells with retroviral mdr 1-coexpression vectors. Hum. Gene Ther. 9:33-42.
15. Hildinger, M., H. G. Eckert, A. J. Schilz, J. John, W. Ostertag, and C. Baum. 1998. FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells. Gene Ther. 5:1575-1579.
16. Kim, S. H., S. S. Yu, J. S. Park, P. D. Robbins, C. S. An, and S. Kim. 1998. Construction of retroviral vectors with improved safety, gene expression, and versatility. J. Virol. 72:994-1004.
17. Krall, W. J., D. C. Skelton, X. J. Yu, I. Riviére, P. Lehn, R. C. Mulligan, and D. B. Kohn. 1995. Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells. Gene Ther. 3:37-48.
18. Matsumoto, K., K. Montzaka Wassarman, and A. P. Wolffe. 1998. Nuclear history of a pre-mRNA determines the translational activity of cytoplasmic mRNA. EMBO J. 17:2107-2121.
19. Miller, A. D., and D. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-990.
20. Miller, A. D., D. G. Miller, J. V. Garcia, and C. M. Lynch. 1993. Use of retroviral vectors for gene transfer and expression. Methods Enzymol. 217: 581-599.
21. Mulligan, R. C. 1993. The basic science of gene therapy. Science 260:926-932.
22. Munk, C., J. Lohler, V. Prassolov, U. Just, M. Stockschlader, and C. Stocking. 1997. Amphotropic murine leukemia viruses induce spongiform encephalomyelopathy. Proc. Natl. Acad. Sci. USA 94:5837-5842.
23. Otto, E., A. Jones-Trower, E. F. Vanin, K. Stambaugh, S. N. Mueller, W. F. Anderson, and G. J. McGarrity. 1994. Characterization of a replicationcompetent retrovirus resulting from recombination of packaging and vector sequences. Hum. Gene Ther. 5:567.
24. Pawliuk, R., C. J. Eaves, and R. K. Humphries. 1997. Sustained high-level reconstitution of the hematopoietic system by preselected hematopoietic cells expressing a transduced cell-surface antigen. Hum. Gene Ther. 8:1595-1604.
25. Portis, J. L., G. J. Spangrude, and F. J. McAtee. 1994. Identification of a sequence in the unique 5′ open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus. J. Virol. 68:3879-3887.
26. Riviére. I., K. Brose, and R. C. Mulligan. 1995. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc. Natl. Acad. Sci. USA 92:6733-6737.
27. Schilz, A. J., G. Brouns, H. Knobeta, O. G. Ottmann, D. Hoelzer, A. A. Fauser, A. J. Thrasher, and M. Grez. 1998. High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum-free conditions. Blood 92:3163-3171.
28. Wolff, L., J. Kaminchick, W. D. Hankins, and S. K. Ruscetti. 1985. Sequence comparison of the anemia- and polycythemia-inducing strains of Friend spleen focus-forming virus. J. Virol. 53:570-578.